340B Drug Pricing Program
Recent data released by the Health Resources and Services Administration show that drug purchases made under the 340B Drug Pricing Program totaled $81.4 billion in 2024.
This webinar reviews key provisions proposed in the Outpatient, Ambulatory Surgical Center Final Rule for CY 2026. Some of the topics discussed include OPPS payment update and area wage index, Payment policies for drugs, biologicals and radiopharmaceuticals, Site-neutral payments, Behavioral health…
AHA 340B Advocacy Alliance - December 2, 2025.
AHA 340B Advocacy Alliance for December 1, 2025.
The AHA, the Maine Hospital Association and four safety-net health systems from across the country Dec. 1 filed a lawsuit in the U.S. District Court for the District of Maine to challenge the 340B Rebate Model Pilot Program.
Today, the American Hospital Association (AHA), the Maine Hospital Association (MHA) and four safety-net health systems from across the country filed a lawsuit in the United States District Court for the District of Maine to stop unlawful changes to a critical program that provides lower-cost drugs…
AHA 340B Advocacy Alliance for November 25, 2025.
AHA Board Chair Tina Freese Decker talks with AHA VP Aimee Kuhlman and Monument Health CEO Paulette Davidson about the benefits of the 340B program.
Learn what the HHS 340B Drug Pricing Program is and what 340B hospitals are. The program allows 340B hospitals to stretch limited federal resources to reduce the price of outpatient pharmaceuticals for patients by providing 340B drug pricing discounts and expand health services to the patients and…
In this Leadership Dialogue conversation, Tina Freese Decker, president and CEO of Corewell Health and 2025 AHA board chair, joins Aimee Kuhlman, vice president of advocacy grassroots and government relations at the AHA, and Paulette Davidson, president and CEO of Monument Health, to unpack what’s…